Ullrich Schwertschlag

2.5k citations
50 papers · 1.9k indexed · 1 hit paper · h-index 18

Ullrich Schwertschlag

50 papers receiving 1.9k citations

Hit Papers

Anti–Interleukin-12 Antibody for Active Crohn's Disease6282004202620112018200400600

Peers

Ullrich Schwertschlag
Comparison fields: 5 of 100
  • Immunology 811
  • Otorhinolaryngology 89
  • Genetics 501
  • Dermatology 153
  • Hematology 177
Replace Bernt van den Blink with:
Bernt van den Blink Netherlands
Paula Jardieu United States
Anthony W.I. Lo Hong Kong
A D Steinberg United States
Mayumi Tamari Japan
Sérgio Zucoloto Brazil
Hoshio Hiraide Japan
Damon J. Tumes Australia
Yuki Moritoki Japan
K Higashino Japan
Ullrich Schwertschlag relative to Bernt van den Blink Netherlands Bernt van den Blink's profile →
Citations per field
00.5×4.4×
Bernt van den Blink · 1×
Citations per year

Countries citing papers authored by Ullrich Schwertschlag

Since Specialization
Citations

This map shows the geographic impact of Ullrich Schwertschlag's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ullrich Schwertschlag with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ullrich Schwertschlag more than expected).

Fields of papers citing papers by Ullrich Schwertschlag

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ullrich Schwertschlag. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ullrich Schwertschlag. The network helps show where Ullrich Schwertschlag may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Ullrich Schwertschlag, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Ullrich Schwertschlag Line = papers co-authored together Ullrich Schwertschlag links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20232
2 20144
3 20136
4 20139
5
MER-1001, a novel polymeric prodrug of camptothecin, is a potent inhibitor of LS174 and A2780 human tumor xenografts in a mouse model
20076
6
A phase I study of the safety, tolerability, and pharmacokinetics of intravenous XMT-1001 in patients with advanced solid tumors.
20073
7 20055
8 20049
9 200424
10 2003106
11 200217
12 200141
13 2001148
14 1999146
15 199753
16 19956
17 19933
18 19865
19 198642
20 19786

About Ullrich Schwertschlag

Ullrich Schwertschlag is a scholar working on Gastroenterology, Biochemistry and Immunology, having authored 50 papers that have together received 1.9k indexed citations. Recurring topics across this work include Gastrointestinal motility and disorders (5 papers), Immune Cell Function and Interaction (5 papers), Renin-Angiotensin System Studies (5 papers), Eicosanoids and Hypertension Pharmacology (4 papers), Electrolyte and hormonal disorders (4 papers), Neuroendocrine regulation and behavior (4 papers), Gastroesophageal reflux and treatments (3 papers) and Ion Transport and Channel Regulation (3 papers). The work is most often cited by research in Immunology (811 citations), Otorhinolaryngology (89 citations) and Genetics (501 citations). Ullrich Schwertschlag has collaborated with scholars based in United States, Germany and Canada. Frequent co-authors include E. Hackenthal, Ivan J. Fuss, Martha Quezado, Ronald L. Hornung, Warren Strober, Jochen Salfeld, Charles O. Elson, Daniel H. Present, William J. Sandborn and Nancy Goodman. Their work appears in journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026